Harvard Bioscience Inc. (HBIO)
NASDAQ: HBIO
· Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM
Harvard Bioscience Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -50.34M | 18K | -4.8M | -2.93M | -4.69M | -1.82M | -1.24M | -980K | 622K | -1.67M | -3.4M | 2.44M | -6.88M | 961K | -170K | -410K | -669K |
Depreciation & Amortization | 1.66M | 1.72M | 1.81M | 1.76M | 1.74M | 1.77M | 1.78M | 1.72M | 1.72M | 1.96M | 1.94M | 1.83M | 1.85M | 1.92M | 1.88M | 1.91M | 1.91M |
Stock-Based Compensation | 600K | 961K | 1.05M | 1.28M | 1.05M | 1.38M | 1.36M | 1.1M | 1.15M | 1.01M | 1.14M | 1.24M | 1.02M | 1.03M | 1M | 1.16M | 968K |
Other Working Capital | n/a | 886K | 1.75M | -902K | -848K | 2.12M | 190K | -296K | 69K | 3.22M | -758K | -3.31M | -851K | -1.11M | -42K | 35K | -925K |
Other Non-Cash Items | n/a | -1.1M | 1.63M | 5.86M | 3.39M | 333K | -1.14M | 1.65M | -333K | 70K | 70K | -3.83M | 70K | 70K | 70K | 123K | 17K |
Deferred Income Tax | n/a | 724K | -407K | 229K | 178K | 244K | 6K | 141K | -55K | -254K | -1.2M | 1.16M | -123K | 168K | -195K | -303K | n/a |
Change in Working Capital | n/a | -593K | -130K | -1.58M | 1.71M | 2.39M | 3.59M | -83K | -1.3M | 1.56M | 2.11M | -3.03M | 2.08M | -4.04M | -3.25M | -1.72M | -1.19M |
Operating Cash Flow | 2.99M | 1.73M | -842K | -846K | 1.4M | 4.3M | 4.36M | 3.55M | 1.81M | 2.68M | 649K | -190K | -1.99M | 117K | -660K | 768K | 1.04M |
Capital Expenditures | -513K | -301K | -657K | -966K | -720K | -1.06M | -401K | -625K | -224K | -235K | -442K | -442K | -471K | -358K | -480K | -206K | -301K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -512K | n/a | n/a | 512K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | 1.42M | 495K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -170K | -165K | -454K | 1.28M | -75K | 512K | -184K | -108K | 512K | -1.59M | n/a | n/a | n/a | -1.2M | n/a | n/a | -150K |
Investing Cash Flow | -683K | -466K | -1.11M | 458K | -225K | -1.06M | -401K | -625K | 288K | -235K | -442K | -442K | -471K | -358K | -480K | -206K | -301K |
Debt Repayment | n/a | -1M | 2.25M | n/a | -1.02M | -2.25M | -2.75M | -2.7M | -2.84M | -2.5M | 700K | -550K | 564K | 3.05M | 1.9M | -500K | -4.5M |
Common Stock Repurchased | n/a | n/a | 59K | -12K | -47K | 451K | n/a | -295K | -156K | -461K | -387K | -279K | -501K | -861K | -1.66M | -526K | -464K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | -481K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.2M | -357K | -146K | 177K | -47K | -1.39M | n/a | 325K | 104K | 231K | 64K | 251K | 31K | -861K | -1.56M | 308K | -565K |
Financial Cash Flow | -1.2M | -1.36M | 2.1M | 177K | -1.05M | -4.12M | -2.75M | -2.38M | -2.89M | -2.73M | 377K | -578K | 94K | 2.59M | 385K | -90K | -3.14M |
Net Cash Flow | 1.44M | -461K | 521K | -207K | -28K | -1.06M | 999K | 535K | -719K | -636K | 885K | -1.17M | -2.39M | 2.27M | -689K | 422K | -2.5M |
Free Cash Flow | 2.47M | 1.42M | -1.5M | -1.81M | 683K | 3.24M | 3.96M | 2.93M | 1.59M | 2.44M | 207K | -632K | -2.46M | -241K | -1.14M | 562K | 736K |